Walleye Trading LLC Akebia Therapeutics, Inc. Transaction History

Walleye Trading LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.26 - $3.34 $101,476 - $149,969	-44,901 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.88 $105,496 - $174,180	-44,892 Reduced 49.99%	44,901 $129,000
Q2 2021 Aug 16, 2021	BUY	$2.83 - $4.2 $203,624 - $302,198	71,952 Added 403.3%	89,793 $340,000
Q1 2021 May 17, 2021	SELL	$2.92 - $5.06 $53,935 - $93,463	-18,471 Reduced 50.87%	17,841 $60,000
Q4 2020 Feb 16, 2021	BUY	$2.22 - $3.78 $80,612 - $137,259	36,312 New	36,312 $102,000
Q3 2019 Nov 14, 2019	SELL	$3.55 - $5.4 $20,980 - $31,914	-5,910 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.1 - $8.05 $24,230 - $47,575	5,910 New	5,910 $29,000
Q2 2018 Aug 14, 2018	SELL	$9.15 - $11.34 $132,675 - $164,430	-14,500 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$9.53 - $15.68 $138,185 - $227,360	14,500 New	14,500 $138,000

121

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $338M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.